Duchesnay USA, Inc.
4 drugs in NADAC|0 Generic,4 Brand
Duchesnay USA, Inc. lists 4 NDCs in the CMS NADAC file (0 generic, 4 brand), at an average NADAC of $7.28 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
4
0G / 4B
Avg Price / Unit
$7.2842
$1.68 – $11.12
Avg 7d Change
+0.04%
Across 4 drugs with changes
7d Activity
of 4 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
doxylamine succinate and pyridoxine hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Antihistamine therapeutic class
Review the broader class where Duchesnay USA, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Duchesnay USA, Inc. make?
Duchesnay USA, Inc. lists 4 NDCs in the CMS NADAC file — 0 generic and 4 brand products.
What is the average price of Duchesnay USA, Inc. drugs?
The average NADAC across Duchesnay USA, Inc.'s portfolio is $7.2842 per unit, ranging from $1.6758 to $11.1153.
What types of drugs does Duchesnay USA, Inc. make?
Duchesnay USA, Inc. makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Antihistamine (2), Vitamin B6 Analog (2), Estrogen Agonist/Antagonist (2).
Has Duchesnay USA, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Duchesnay USA, Inc. in the openFDA feed.
How has Duchesnay USA, Inc.'s pricing changed recently?
Over the past 7 days, 2 Duchesnay USA, Inc. products rose and 2 fell, with a portfolio-wide average change of +0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BONJESTA ER 20-20 MG TABLET doxylamine succinate and pyridoxine hydrochloride | $11.1153 per EA | +0.01% |
OSPHENA 60 MG TABLET Ospemifene | $8.1728 per EA | -0.06% |
OSPHENA 60 MG TABLET Ospemifene | $8.1728 per EA | -0.06% |
DICLEGIS DR 10-10 MG TABLET doxylamine succinate and pyridoxine hydrochloride | $1.6758 per EA | +0.27% |